Nucci Carlo, Martucci Alessio, Cesareo Massimo, Garaci Francesco, Morrone Luigi Antonio, Russo Rossella, Corasaniti Maria Tiziana, Bagetta Giacinto, Mancino Raffaele
Ophthalmology Unit, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
Ophthalmology Unit, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
Prog Brain Res. 2015;221:49-65. doi: 10.1016/bs.pbr.2015.04.010. Epub 2015 Jul 2.
Glaucoma is the leading cause of irreversible blindness worldwide. Although the intraocular pressure (IOP) has been considered for long time the key point and the only treatable risk factor of the disease, there are cases in which glaucoma continues to progress despite normal IOP values. Vision loss in glaucoma is related to a selective decrease in the number of retinal ganglion cells by apoptosis that is associated to alterations of the central visual pathways. Interestingly, similar events have been also described in disorders of the central nervous system (CNS), such as Alzheimer's disease, Parkinson's disease, Leber's hereditary optic neuropathy, and cerebrovascular diseases. In this review, we discuss recent evidence supporting pathological links between glaucoma and disorders of the CNS.
青光眼是全球不可逆性失明的主要原因。尽管长期以来眼压一直被视为该疾病的关键因素以及唯一可治疗的风险因素,但仍有一些病例,即便眼压值正常,青光眼仍会继续发展。青光眼导致的视力丧失与视网膜神经节细胞数量因凋亡而选择性减少有关,这种凋亡与中枢视觉通路的改变相关。有趣的是,在中枢神经系统(CNS)疾病中也描述了类似情况,如阿尔茨海默病、帕金森病、Leber遗传性视神经病变和脑血管疾病。在本综述中,我们讨论了支持青光眼与中枢神经系统疾病之间病理联系的最新证据。